Shilpa Medicare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE790G01031
  • NSEID: SHILPAMED
  • BSEID: 530549
INR
331.25
-2.7 (-0.81%)
BSENSE

Dec 05

BSE+NSE Vol: 1.06 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
691.43
636.31
573.15
524.06
532.63
501.80
450.91
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
691.43
636.31
573.15
524.06
532.63
501.80
450.91
Raw Material Cost
242.68
175.27
217.36
217.10
170.20
183.53
154.61
Purchase of Finished goods
11.51
9.02
8.55
10.23
7.53
9.15
5.44
(Increase) / Decrease In Stocks
-69.09
30.61
-12.02
-6.93
0.50
-24.83
-14.07
Employee Cost
164.87
148.29
145.91
146.42
123.44
108.99
96.44
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.01
0.00
0.00
0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
141.54
113.60
105.13
124.47
145.92
90.52
111.68
Total Expenditure (Excl Depreciation)
491.51
476.79
464.94
491.29
447.59
367.37
354.10
Operating Profit (PBDIT) excl Other Income
199.92
159.52
108.21
32.77
85.04
134.43
96.81
Other Income
8.13
14.52
3.74
12.49
3.27
14.68
7.80
Operating Profit (PBDIT)
208.05
174.04
111.95
45.26
88.31
149.11
104.61
Interest
34.45
49.29
41.38
23.06
21.90
7.96
2.28
Exceptional Items
0.00
0.00
0.00
0.00
8.91
60.84
0.00
Gross Profit (PBDT)
173.60
124.75
70.57
22.20
75.32
201.99
102.33
Depreciation
58.74
55.39
54.54
45.73
36.81
25.02
21.32
Profit Before Tax
114.86
69.36
16.03
-23.53
38.51
176.97
81.01
Tax
23.06
33.44
9.71
-10.22
15.12
45.14
15.24
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
91.80
35.92
6.32
-13.31
23.39
131.84
65.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
91.80
35.92
6.32
-13.31
23.39
131.84
65.77
Share in Profit of Associates
-0.85
-3.91
-3.57
-2.93
-1.89
-0.65
-0.33
Minority Interest
0.00
-0.01
0.04
-1.58
0.05
0.50
1.08
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
90.95
32.00
2.79
-17.81
21.55
131.69
66.52
Equity Capital
9.78
9.78
8.68
8.68
8.15
8.15
8.15
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
1,489.96
0.00
0.00
Earnings per share (EPS)
4.65
1.64
0.32
-2.05
2.64
16.16
8.16
Diluted Earnings per share
4.65
1.65
0.32
-2.05
2.64
16.15
8.16
Operating Profit Margin (Excl OI)
28.91%
25.07%
18.88%
6.25%
15.97%
26.79%
21.47%
Gross Profit Margin
25.11%
19.61%
12.31%
4.24%
14.14%
40.25%
22.69%
PAT Margin
13.15%
5.03%
0.48%
-3.1%
4.04%
26.14%
14.51%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 8.66% vs 11.02% in Sep 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is 184.22% vs 1,046.95% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 25.33% vs 47.42% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is -30.11% vs 19.12% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Shilpa Medicare With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
691.43
2,041.56
-1,350.13
-66.13%
Other Operating Income
0.00
0.00
0.00
Total Operating income
691.43
2,041.56
-1,350.13
-66.13%
Raw Material Cost
242.68
1,100.52
-857.84
-77.95%
Purchase of Finished goods
11.51
77.79
-66.28
-85.20%
(Increase) / Decrease In Stocks
-69.09
-3.83
-65.26
-1,703.92%
Employee Cost
164.87
365.41
-200.54
-54.88%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
141.54
278.23
-136.69
-49.13%
Total Expenditure (Excl Depreciation)
491.51
1,818.12
-1,326.61
-72.97%
Operating Profit (PBDIT) excl Other Income
199.92
223.44
-23.52
-10.53%
Other Income
8.13
59.10
-50.97
-86.24%
Operating Profit (PBDIT)
208.05
282.54
-74.49
-26.36%
Interest
34.45
46.44
-11.99
-25.82%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
173.60
236.10
-62.50
-26.47%
Depreciation
58.74
74.78
-16.04
-21.45%
Profit Before Tax
114.86
161.32
-46.46
-28.80%
Tax
23.06
53.94
-30.88
-57.25%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
91.80
107.38
-15.58
-14.51%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
91.80
107.38
-15.58
-14.51%
Share in Profit of Associates
-0.85
0.00
-0.85
Minority Interest
0.00
-3.12
3.12
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
90.95
104.26
-13.31
-12.77%
Equity Capital
9.78
30.62
-20.84
-68.06%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.65
6.81
-2.16
-31.72%
Diluted Earnings per share
4.65
6.81
-2.16
-31.72%
Operating Profit Margin (Excl OI)
28.91%
10.94%
0.00
17.97%
Gross Profit Margin
25.11%
11.56%
0.00
13.55%
PAT Margin
13.15%
5.26%
0.00
7.89%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 691.43 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 8.66% vs 11.02% in Sep 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 90.95 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 184.22% vs 1,046.95% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 199.92 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 25.33% vs 47.42% in Sep 2024

Half Yearly - Interest
Interest 34.45 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -30.11% vs 19.12% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.91%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024